Influence of process parameters and equipment on dry foam formulation properties using indomethacin as model drug
Contributor(s):: Sprunk, A, Page, S, Kleinebudde, P
Dry foam technology was developed to overcome insufficient oral bioavailability of poorly soluble and wettable active pharmaceutical ingredients (APIs). It is intended to enable a faster and more efficient dissolution by avoiding API agglomeration and floating of non-wetted API particles. The aim...